酶替代治疗的戈谢病合并丛状动脉病的肺动脉高压 - Suppr

Suppr

超能文献

Pulmonary arterial hypertension with plexogenic arteriopathy in enzyme-substituted Gaucher disease.

作者信息

den Bakker Michael A, Grünberg Katrien, Boonstra Anco, van Hal Peter Th W, Hollak Carla E M

出版信息

Histopathology. 2012 Aug;61(2):324-6. doi: 10.1111/j.1365-2559.2012.04261.x. Epub 2012 Jun 13.

DOI:10.1111/j.1365-2559.2012.04261.x

PMID:22690977

Abstract

摘要

相似文献

Pulmonary arterial hypertension with plexogenic arteriopathy in enzyme-substituted Gaucher disease.酶替代治疗的戈谢病合并丛状动脉病的肺动脉高压

Histopathology. 2012 Aug;61(2):324-6. doi: 10.1111/j.1365-2559.2012.04261.x. Epub 2012 Jun 13.

Pulmonary hypertension in type 1 Gaucher's disease. Comité d'Evaluation du Traitement de la Maladie de Gaucher.1型戈谢病中的肺动脉高压。戈谢病治疗评估委员会。

Lancet. 1998 Jul 18;352(9123):240. doi: 10.1016/s0140-6736(05)77849-1.

Pulmonary hypertension in Gaucher's disease.戈谢病中的肺动脉高压。

Lancet. 1998 Aug 15;352(9127):580. doi: 10.1016/S0140-6736(05)79295-3.

Alglucerase treatment of type 1 Gaucher disease with pulmonary involvement.用阿糖苷酶治疗1型戈谢病合并肺部受累。

Respir Med. 1998 Dec;92(12):1370-2. doi: 10.1016/s0954-6111(98)90145-7.

Pulmonary hypertension developing after alglucerase therapy in two patients with type 1 Gaucher disease complicated by the hepatopulmonary syndrome.两名1型戈谢病合并肝肺综合征患者在接受阿糖苷酶治疗后出现肺动脉高压。

Ann Intern Med. 1996 Dec 1;125(11):901-4. doi: 10.7326/0003-4819-125-11-199612010-00005.

Cholangiocarcinoma occurring in a patient with type 1 Gaucher disease treated with velaglucerase alfa enzyme replacement therapy: First case report.1型戈谢病患者接受维拉苷酶α酶替代疗法治疗后发生胆管癌：首例病例报告。

Blood Cells Mol Dis. 2018 Feb;68:112-114. doi: 10.1016/j.bcmd.2017.05.010. Epub 2017 May 24.

Early access experience with VPRIV(®): recommendations for 'core data' collection.VPRIV(®)的早期使用经验：“核心数据”收集建议

Blood Cells Mol Dis. 2011 Aug 15;47(2):140-2. doi: 10.1016/j.bcmd.2010.10.015. Epub 2010 Dec 13.

Pulmonary hypertension in two patients with type I Gaucher disease while on alglucerase therapy.两名I型戈谢病患者在接受阿糖苷酶治疗期间出现肺动脉高压。

Acta Haematol. 1997;98(1):47-50. doi: 10.1159/000203562.

IgM monoclonal component associated with type I Gaucher disease resolved after enzyme replacement therapy: a case report.与 I 型戈谢病相关的 IgM 单克隆成分在酶替代治疗后得到解决：病例报告。

J Inherit Metab Dis. 2009 Dec;32 Suppl 1:S265-7. doi: 10.1007/s10545-009-1207-8. Epub 2009 Jun 27.

Gaucher disease: resetting the clinical and scientific agenda.戈谢病：重置临床与科学议程。

Am J Hematol. 2009 Apr;84(4):205-7. doi: 10.1002/ajh.21384.

引用本文的文献

Interstitial lung disease in lysosomal storage disorders.溶酶体贮积症相关性间质性肺疾病。

Eur Respir Rev. 2021 Apr 29;30(160). doi: 10.1183/16000617.0363-2020. Print 2021 Jun 30.

Epidemiology, Pathogenesis, and Clinical Approach in Group 5 Pulmonary Hypertension.5型肺动脉高压的流行病学、发病机制及临床处理方法

Front Med (Lausanne). 2021 Mar 25;7:616720. doi: 10.3389/fmed.2020.616720. eCollection 2020.

Lessons from lung transplantation: Cause for redefining the pathophysiology of pulmonary hypertension in gaucher disease.肺移植的经验教训：重新定义戈谢病肺动脉高压病理生理学的缘由

Respir Med Case Rep. 2019 Jun 29;28:100893. doi: 10.1016/j.rmcr.2019.100893. eCollection 2019.

Medical Management of Pulmonary Hypertension with Unclear and/or Multifactorial Mechanisms (Group 5): Is There a Role for Pulmonary Arterial Hypertension Medications?肺动脉高压不明和/或多因素机制的医学管理（第 5 组）：肺动脉高压药物是否有作用？

Curr Hypertens Rep. 2017 Oct 18;19(11):86. doi: 10.1007/s11906-017-0783-5.

Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy.在酶替代疗法时代，血浆壳三糖苷酶评估非神经病变型戈谢病严重程度及病情进展的价值。

J Inherit Metab Dis. 2014 Nov;37(6):991-1001. doi: 10.1007/s10545-014-9711-x. Epub 2014 May 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验